Telemedicine in Resource-Limited Settings to Optimize Care for Multidrug-Resistant Tuberculosis
G Khai Lin Huang, Gibson Pawape, Magdalene Taune, Stenard Hiasihri, Pilar Ustero, Daniel P O'Brien, Philipp du Cros, Steve Graham, Richard Wootton, Suman S Majumdar
Frontiers in Public Health | Frontiers Media SA | Published : 2019
The emergence and spread of multidrug-resistant tuberculosis (MDR-TB) poses a major threat to the global targets for TB control. In recent years, an evolving science and evidence base for MDR-TB has led to much needed changes in international guidelines promoting the use of newer TB drugs and regimens for MDR-TB, however, there remains a significant implementation gap. Due to the complexity of treating MDR-TB, management of cases is often supported by an expert multidisciplinary team, or clinical expert group. This service is often centralized, and may be delivered through a telemedicine platform. We have implemented a Web-based “store-and-forward” telemedicine service to optimize MDR-TB pat..View full abstract
The Reducing the Impact of Drug-resistant TB (RID-TB) project was supported by the Australian Government and implemented by the Burnet Institute. The Stronger Systems for Drug-resistant Tuberculosis and Malaria research grant was supported by the Australian Government and implemented by the Menzies School of Health Research and the Burnet Institute. The views expressed in this publication are the author's alone and are not necessarily the views of the Australian Government.